Juan Morote

发表

Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.

J. Morote, I. de Torres, J. Andreu, 1997, The Journal of urology.

Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition.

F. Gómez‐Veiga, J. Ponce-Reixa, S. Martínez-Breijo, 2013 .

[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer].

M. Climent, J. Morote, B. Miñana, 2012, Actas urologicas espanolas.

Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

J. Morote, J. Planas, J. Placer, 2012, Urologia Internationalis.

Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.

J. Lorente, G. Encabo, C. Raventós, 1996, The Journal of urology.

The role of prostate-specific antigen in light of new scientific evidence: An update in 2020.

J. Cózar, M. Álvarez-Cubero, J. Morote, 2020, Actas urologicas espanolas.

Utility of the RENAL index -Radius; Exophytic/endophytic; Nearness to sinus; Anterior/posterior; Location relative to polar lines- in the management of renal masses.

J. Morote, D. Lorente, E. Trilla, 2016 .

Utility of the RENAL index -Radius; Exophytic/endophytic; Nearness to sinus; Anterior/posterior; Location relative to polar lines- in the management of renal masses.

D. Lorente, J. Morote, E. Trilla, 2016, Actas urologicas espanolas.

A review of the Moses effect and its applications in endourology

J. Placer, E. Trilla, A. Narváez, 2024, Current Urology.

Current status of tissue engineering applied to bladder reconstruction in humans.

J. Morote, C. Raventós, C. Raventós, 2018, Actas urologicas espanolas.

Cognitive function in patients on androgen suppression: A prospective, multicentric study.

J. Morote, J. Angulo, J. Álvarez-Ossorio, 2018, Actas urologicas espanolas.

A systematic review of methods for quantifying serum testosterone in patients with prostate cancer who underwent castration.

A. Celma, L. Regis, I. Comas, 2018 .

A systematic review of methods for quantifying serum testosterone in patients with prostate cancer who underwent castration.

J. Morote, J. Planas, R. Ferrer, 2017, Actas urologicas espanolas.

Measurement of serum testosterone during androgenic suppression in patients with prostate cancer: A systematic review.

J. Morote, A. Celma, A. Celma, 2016, Actas urologicas espanolas.

Measurement of serum testosterone during androgenic suppression in patients with prostate cancer: A systematic review.

J. Morote, J. Planas, A. Celma, 2016 .

Bone health in patients with prostate cancer.

E. Solsona, A. Rodríguez-Antolín, J. Cózar, 2014, Actas urologicas espanolas.